From: The impact of peri-natal stress on psychosis risk: results from the Bo-FEP incidence study
Health status of the mothers | Cases | Controls |
---|---|---|
n (%) | 42 (100.0) | 26 (100.0) |
 First child | 29 (69.0) | 15 (57.7) |
 Second child | 8 (19.0) | 8 (30.8) |
 Third or further child | 5 (11.9) | 3 (11.5) |
Mean age of the parents at cases’ births (SD) | ||
 Mothers’ age | 26.88 (5.4) | 28.46 (5.3) |
 Fathers’ age | 31.08 (6.06) | 31.81 (5.7) |
Mean age of the mothers at the interview (SD) | 58.57 (9.5) | 58.96 (5.4) |
Maternal disorders history, n (%) | 42 (100.0) | 26 (100.0) |
 Negative*** | 20 (46.6) | 24 (92.3) |
 Positive*** | 22 (52.4) | 2 (7.7) |
 Endocrine-Metabolic disorders | 5 (11.9) | 0 (.0) |
 Cardio-vascular disorders | 4 (9.5) | 0 (0.0) |
 Respiratory disorders | 2 (4.8) | 0 (0.0) |
 Neurological disorders | 1 (2.4) | 0 (0.0) |
 Gynaecological disorders * | 9 (21.4) | 1 (3.8) |
 Other | 9 (21.4) | 2 (7.7) |
Pathological obstetric history, n (%) | 42 (100.0) | 26 (100.0) |
 Not applicable | 29 (69.0) | 14 (53.8) |
 Negative | 10 (23.8) | 10 (38.5) |
 Positive | 3 (7.1) | 2 (7.7) |
OCs, n (%) | 42 (100.0) | 26 (100.0) |
 Present | 27 (65.9) | 20 (76.9) |
 Absent | 14(34.1) | 6 (23.1) |
Negatives memories (e.g. trauma), n (%) | 42 (100.0) | 26 (100.0) |
 No*** | 18 (42.9) | 24 (92.3) |
 Yes*** | 24 (57.1) | 2 (7.7) |
Use of drugs-alcohol-substances in pregnancy | ||
 Not-users | 24 (57.1) | 14 (53.8) |
 Users | 18 (42.9) | 12 (46.2) |
Alcohol during pregnancy, n (%) | 15 (35.7) | 11 (42.2) |
 Monthly or less | 3 (7.1) | 1 (3.8) |
 2–3 time/month | 5 (11.9) | 1 (3.8) |
 2–3 times/week | 5 (11.9 | 8 (30.8) |
 Every day | 2 (4.8) | 1 (3.8) |
Smoking during pregnancy, n (%) | 7 (15.8) | 3 (11.5) |
 6–9 sigarettes/die | 6 (14.3) | 2 (7.7) |
 10–20 sigarettes/die | 1 (2.4) | 1 (3.8) |
 Other smokers at home | 18 (43.9) | 14 (56.0) |
 Other Substances during pregnancy, n (%) | 0 (0.0) | 0 (0.0) |
Medicinal drugs during pregnancy, n (%) | 35 (100.0) | 24 (100.0) |
 Yes* | 12 (34.3) | 3 (12.5) |
 No* | 23 (65.7) | 21 (87.5) |
 Anti-inflammatory drugs** | 7 (20.6) | 0 (0.0) |